Impact factor

Research: Surgeons, Hospitals Involved in Exceptional Research Have Lower Patient Mortality Rates, Fewer Complications

Retrieved on:

Wednesday, April 3, 2024

Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.

Key Points:

Surgeons and hospitals who conduct the most leading-edge research achieve lower rates of patient mortality and complications than those who do not, according to findings released today by Avant-garde Health.
Patients under the care of top surgeon-researchers showed a 5% lower rate of post-discharge complications and a 5% lower rate of mortality, within 30 days post-discharge, according to the research.
All 4,500 physicians and 350 hospitals being honored are listed on the Research All-Stars site .
In addition, a significant portion of the top surgeon-researchers – 47.1% on average – served as the leading or senior authors of their research.

Wolters Kluwer delivers strong Lippincott journal performance in 2023 Journal Citation Reports

Retrieved on:

Wednesday, August 9, 2023

Wolters Kluwer Health today announced strong results for the Lippincott portfolio of journals in the 2022 Journal Impact Factor (JIF), the journal metric released annually by Clarivate Analytics as part of the Journal Citation Reports (JCR).

Key Points:

Wolters Kluwer Health today announced strong results for the Lippincott portfolio of journals in the 2022 Journal Impact Factor (JIF), the journal metric released annually by Clarivate Analytics as part of the Journal Citation Reports (JCR).
The 2023 rankings featured 387 Wolters Kluwer journals, with more than half (52%) receiving improved rankings from the previous year and an overall net increase for the portfolio.
To learn more about the titles within the Wolters Kluwer Lippincott publishing lineup, please visit lww.com .
The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Human Factors and Ergonomics Society's Human Factors Journal Receives Prestigious Recognition

Retrieved on:

Tuesday, July 18, 2023

The Human Factors and Ergonomics Society ( HFES ), the world’s largest scientific association for human factors/ergonomics professionals, announced that the society’s journal, Human Factors, achieved its second-highest rating at 3.3 from the annual Journal Citation Reports (JCR) published by Clarivate.

Key Points:

The Human Factors and Ergonomics Society ( HFES ), the world’s largest scientific association for human factors/ergonomics professionals, announced that the society’s journal, Human Factors, achieved its second-highest rating at 3.3 from the annual Journal Citation Reports (JCR) published by Clarivate.
First published in 1958, Human Factors is the flagship journal of the Human Factors and Ergonomics Society, covering a wide variety of topics, including automation, human systems integration, industrial engineering, robotics and more.
Editor-in-Chief of Human Factors, Rob Radwin, said, “It’s encouraging that the journal has maintained its strong level of impact this year, the new method of calculating impact factors notwithstanding.” The publication looks forward to cultivating further innovations, celebrating the accomplishments and implementing forward steps to improving human factors and ergonomics research and practice.
For more details and additional information on the latest findings in human factors/ergonomics research and practice, please visit Human Factors and Ergonomic Society’s Journals and Proceedings website page.

Clarivate Unveils Journal Citation Reports 2023 - a Trusted Resource to Support Research Integrity and Promote Accurate Journal Evaluation

Retrieved on:

Wednesday, June 28, 2023

LONDON, June 28, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released the 2023 update to its annual Journal Citation Reports™ (JCR)™. This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines. Only journals that have met the rigorous quality standards for inclusion in the Web of Science™ index are selected, to ensure that users can confidently rely on the information and data provided to foster and support collective community goals to adhere to research integrity norms.

Key Points:

This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines.
For nearly half a century, the information released in the annual Journal Citation Reports has been trusted by the global academic community as a reliable resource for identifying leading journals in their fields.
It provides clarity of key citation impact trends, powered by a range of indicators, descriptive data and compelling visualizations, enabling meaningful comparisons and insights.
The annual reports incorporate a variety of metrics, including the widely recognized Journal Impact Factor™ (JIF)™ and the Journal Citation Indicator.

Clarivate Unveils Journal Citation Reports 2023 - a Trusted Resource to Support Research Integrity and Promote Accurate Journal Evaluation

Retrieved on:

Wednesday, June 28, 2023

LONDON, June 28, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released the 2023 update to its annual Journal Citation Reports™ (JCR)™. This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines. Only journals that have met the rigorous quality standards for inclusion in the Web of Science™ index are selected, to ensure that users can confidently rely on the information and data provided to foster and support collective community goals to adhere to research integrity norms.

Key Points:

This annual release identifies more than 21,500 high-quality academic journals from across 250+ scientific and research disciplines.
For nearly half a century, the information released in the annual Journal Citation Reports has been trusted by the global academic community as a reliable resource for identifying leading journals in their fields.
It provides clarity of key citation impact trends, powered by a range of indicators, descriptive data and compelling visualizations, enabling meaningful comparisons and insights.
The annual reports incorporate a variety of metrics, including the widely recognized Journal Impact Factor™ (JIF)™ and the Journal Citation Indicator.

LifeOmic and Indiana University School of Medicine Collaborate on the Largest Real-World Intermittent Fasting Study

Retrieved on:

Tuesday, October 4, 2022

INDIANAPOLIS, Oct. 4, 2022 /PRNewswire/ -- LifeOmic, a software company leveraging the cloud, machine learning, and mobile devices to power precision health and wellness solutions, today unveiled findings from a landmark intermittent fasting (IF) study conducted with scientists from Indiana University School of Medicine. The study, published in JMIR mHealth and uHealth, quantifies user retention, fasting patterns, and weight loss in users of LifeOmic's LIFE Apps suite of mobile apps: LIFE Fasting Tracker (LifeOmic's fasting app) and LIFE Extend (LifeOmic's Precision Wellness app). It is the largest research study of its kind to date, following nearly 800,000 users and tracking 26 million fasts over 2 years.

Key Points:

It is the largest research study of its kind to date, following nearly 800,000 users and tracking 26 million fasts over 2 years.
We're proud of our research with renowned scientists at Indiana University School of Medicine, which looks at intermittent fasting behavior in the real world.
Retention, Fasting Patterns, and Weight Loss With an Intermittent Fasting App: Large-Scale, 52-Week Observational Study.
To learn more about LifeOmic visit lifeomic.com
Indiana University School of Medicine:
IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report.

Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Retrieved on:

Monday, August 8, 2022

FREEHOLD, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced a new publication featuring the Company’s QTY protein code technology in Chemical Reviews, a top-ranked peer-reviewed scientific journal and the official journal of American Chemical Society (journal Impact Factor is 72). The publication, entitled “Protein Design: From the Aspect of Water Solubility and Stability,” focuses on the innovative QTY protein design code—co-developed by Avalon—as a novel platform to generate water-soluble proteins for a wide spectrum of biomedical applications. The Company initially licensed the technology from the Massachusetts Institute of Technology (MIT) and has advanced the platform through a sponsored research agreement with the university.

Key Points:

FREEHOLD, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced a new publication featuring the Companys QTY protein code technology in Chemical Reviews, a top-ranked peer-reviewed scientific journal and the official journal of American Chemical Society (journal Impact Factor is 72).
The Company initially licensed the technology from the Massachusetts Institute of Technology (MIT) and has advanced the platform through a sponsored research agreement with the university.
The publication provides a comprehensive review of the QTY protein code design platform.
Our QTY protein design code extends this knowledge, enabling an even more precise understanding and manipulation of protein structures and function.

Clarivate announces changes to the 2023 Journal Citation Reports All Web of Science Core Collection journals, including arts and humanities will have Journal Impact Factors

Retrieved on:

Tuesday, July 26, 2022

This means expanding the JIF from Science Citation Index Expanded (SCIE) and Social Science Citation Index (SSCI) to include journals from the Arts and Humanities Citation Index (AHCI)and the multidisciplinary Emerging Sources Citation Index (ESCI).

Key Points:

This means expanding the JIF from Science Citation Index Expanded (SCIE) and Social Science Citation Index (SSCI) to include journals from the Arts and Humanities Citation Index (AHCI)and the multidisciplinary Emerging Sources Citation Index (ESCI).
I welcome the expansion of the JIF to all journals in Web of Science Core Collection.
These include:
The Journal Citation Indicator, which represents the average category-normalized citation impact for papers published in the prior three-year period.
You can find more information including our suppression policy in the Journal Citation Reports Reference Guide .

Clarivate announces changes to the 2023 Journal Citation Reports All Web of Science Core Collection journals, including arts and humanities will have Journal Impact Factors

Retrieved on:

Tuesday, July 26, 2022

This means expanding the JIF from Science Citation Index Expanded (SCIE) and Social Science Citation Index (SSCI) to include journals from the Arts and Humanities Citation Index (AHCI)and the multidisciplinary Emerging Sources Citation Index (ESCI).

Key Points:

This means expanding the JIF from Science Citation Index Expanded (SCIE) and Social Science Citation Index (SSCI) to include journals from the Arts and Humanities Citation Index (AHCI)and the multidisciplinary Emerging Sources Citation Index (ESCI).
I welcome the expansion of the JIF to all journals in Web of Science Core Collection.
These include:
The Journal Citation Indicator, which represents the average category-normalized citation impact for papers published in the prior three-year period.
You can find more information including our suppression policy in the Journal Citation Reports Reference Guide .

JHLT: Tops in Transplantation

Retrieved on:

Wednesday, June 29, 2022

Journal of Heart and Lung Transplantation increases Impact Factor, maintains #1 ranking among transplantation journals

Key Points:

Journal of Heart and Lung Transplantation increases Impact Factor, maintains #1 ranking among transplantation journals
JHLT'soverall 2021 Impact Factor is 13.569, up from 10.247 in 2020.
ISHLT is the only international interdisciplinary organization focused on interventions for advanced heart and lung disease, including transplantation.
The official publication of the International Society for Heart and Lung Transplantation, the Journal of Heart and Lung Transplantation brings readers essential scholarly and timely information in the field of cardiopulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy.
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical support and innovative therapies.